Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

Polycystic Ovary Syndrome 1Obesity 1

Interventions

Metformin 14Clomiphene 6Progesterone 5Chorionic Gonadotropin 5drospirenone and ethinyl estradiol combination 4Sugars 4Letrozole 4Flutamide 4Estrogens 4Cholecalciferol 4follitropin alfa 3Pioglitazone 3Medroxyprogesterone Acetate 3Glycoprotein Hormones, alpha Subunit 3Estradiol 3Vitamin D 2Testosterone 2Resistance Training 2Raloxifene Hydrochloride 2Ovidrel 2Liraglutide 2Leuprolide 2Glucose Tolerance Test 2Exenatide 2Ethinyl Estradiol 2Contraceptives, Oral 2Continuous Positive Airway Pressure 2saxagliptin 1salicylsalicylic acid 1penclomedine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Polycystic Ovary Syndrome × Sodium-Glucose Transporter 2 Inhibitors × Clear all
NCT02635386 2021-01-29

EQW, DAPA, EQW/DAPA, DAPA/MET ER and PHEN/TPM ER in Obese Women With PolycysticOvary Syndrome (PCOS)

Woman's

Phase 3 Completed
119 enrolled 34 charts
Other

Obesity, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡